ClinicalTrials.Veeva

Menu

Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility

Sanofi logo

Sanofi

Status and phase

Completed
Phase 3

Conditions

Hygiene

Treatments

Drug: Lactic Acid

Study type

Interventional

Funder types

Industry

Identifiers

NCT00783861
LACAC_L_04370

Details and patient eligibility

About

To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Femina (Lactic Acid) Pocket BR.

Enrollment

54 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 18 and 60 years old;
  • Phototype Skin I,II, III e IV
  • Integral skin test in the region;
  • Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria

  • Lactation or gestation
  • Use of Antiinflammatory and/or immunosuppression drugs one month before the study;
  • Personnel history of atopy;
  • History of sensitivity or irritation for topic products;
  • Active cutaneous disease;
  • Use of new drugs or cosmetics during the study;

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

54 participants in 1 patient group

1
Experimental group
Description:
Lactic Acid (Dermacyd Femina)
Treatment:
Drug: Lactic Acid

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems